ESMO 2017: Combination Targeted Adjuvant Therapy Doubles Relapse-free Survival in Stage III Melanoma
Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage…
Browsing: stage 3 melanoma
Australian researchers stopping melanoma in its tracks
A team of Australian researchers has made the ultimate move in the battle to beat…
Investigational immunotherapy was safe, tolerable, showed some activity against melanoma
According to results from a first-in-human phase I clinical trial published in Clinical Cancer Research, a…